Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
Titel:
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
Auteur:
Gimsing, Peter Carlson, Kristina Turesson, Ingemar Fayers, Peter Waage, Anders Vangsted, Annette Mylin, Anne Gluud, Christian Juliusson, Gunnar Gregersen, Henrik Hjorth-Hansen, Henrik Nesthus, Ingerid Dahl, Inger Marie S Westin, Jan Nielsen, Johan Lanng Knudsen, Lene Meldgaard Ahlberg, Lucia Hjorth, Martin Abildgaard, Niels Andersen, Niels Frost Linder, Olle Wisløff, Finn